From Somatic Variants Toward Precision Oncology: An Investigation of Reporting Practice for Next-Generation Sequencing-Based Circulating Tumor DNA Analysis.

Abstract excerpt

BACKGROUND: With the accelerated development of next-generation sequencing (NGS), identified variants, and targeted therapies, clinicians who confront the complicated and multifarious genetic information may not effectively incorporate NGS-based circulating tumor DNA (ctDNA) analysis into routine patient care. Consequently, standardized ctDNA testing reports are of vital importance. In an effort to guarantee...

Topics

Join the communities discussing this publication.

• Biomarkers, Tumor
• Circulating Tumor DNA
• High-Throughput Nucleotide Sequencing
• Mutation
• Neoplasms